DJIA 17,712.66 34.43 0.19%
NASDAQ 4,891.22 27.86 0.57%
S&P 500 2,061.02 4.87 0.24%
market minute promo


company name or ticker
Company Photos
(Click to zoom)

Bristol-Myers Squibb's $1.6 Billion On New Drug Deals Is Well Spent

The Key Contributor Of Roche's Value Is Not In Danger Yet

3 Drugs Stocks On The Rise

Here Is How Much Lawsuits Cost J&J Every Year

3 Little-Known Stocks I'm Glad I Bought

Ophthotech Corp, Portola Pharmaceuticals Inc., and Insys Therapeutics Inc., have been top performers this past year.

2 Tiny Biotechs That Could Have Blockbuster Opportunity

Got risk tolerance? Check out these two small cap biotechs with huge potential.

In Case You Missed It, This New Cancer Care Cost Study Is Extremely Disappointing

We'd like to think that the billions of dollars being spent annually on cancer drug development are making a sizable impact on the lives of cancer patients. But, that may not be the case, according to this latest study.

Bristol-Myers Oncology Drug Opdivo Label Expanded in U.S. - Analyst Blog

Seeking Alpha's Biotech Weekly: AbbVie - Pharmacyclitics, Orexigen Confusion, And More

3 Big Pharma Stocks to Buy in March

Our experts weigh in.
See More Articles...